Patient | Immune status | Lesion | HPV typing using MY09/MY11 degenerate primers | HPV typing using CP65–70 EV specific primers |
---|---|---|---|---|
NHS, normal human skin; SCC, squamous cell carcinoma; ND, not done. | ||||
1 | RTR | Wart | HPV-2a/HPV-57 | HPV-23 rel |
NHS | -ve | -ve | ||
SCC | -ve | HPV-15 | ||
SCC | -ve | HPV-36/RTRX1 | ||
SCC | HPV-17/HPV-38-rel | HPV-36 | ||
SCC | HPV-22 | RTRX1/HPV-38 rel | ||
2 | RTR | Wart | HPV-57 | HPV-38 rel |
Wart | HPV-10 | HPVx14b | ||
NHS | -ve | -ve | ||
3 | RTR | Wart | HPV-10 | RTRX5/RTRX6 |
4 | RTR | Wart | HPV-17 | HPV-23-rel |
NHS | -ve | -ve | ||
5 | RTR | Wart | HPV-10 | HPV-2a/HPV-23-rel/RTRX10 |
6 | RTR | Wart | ND | HPV-23 rel |
Wart | ND | RTRX10 | ||
7 | RTR | Wart | -ve | RTRTX10 rel |
8 | RTR | Wart | HPV-57 | Unknown HPV type |
9 | RTR | Wart | -ve | HPV-23 rel |
10 | RTR | SCC | -ve | HPV-38 rel |
11 | RTR | SCC | -ve | HPV-38 rel |
12 | RTR | SCC | -ve | -ve |
13 | RTR | SCC | -ve | HPVx20 |
14 | RTR | SCC | -ve | HPV-15 |
15 | RTR | NHS | -ve | -ve |
16 | RTR | NHS | -ve | RTRX9/HPV-37/ HPV-15 rel |
17 | ICP | Wart | -ve | HPV-2a/HPV-10 rel |
18 | ICP | Wart | -ve | HPV-20 |
Wart | -ve | HPV-5-rel/HPV-15 rel | ||
19 | ICP | Wart | -ve | HPV-23 rel |
Wart | -ve | HPV-23 rel | ||
Wart | -ve | HPV-20/HPV-38 rel | ||
20 | ICP | Wart | -ve | HPVx2b |
21 | ICP | Wart | -ve | HPV-23 rel |
22 | ICP | SCC | -ve | HPV-20 |
23 | ICP | NHS | -ve | HPV-24/HPV-17 |
24 | ICP | SCC | -ve | -ve |
NHS | -ve | -ve | ||
25 | ICP | SCC | -ve | HPV-20 |
26 | ICP | SCC | -ve | HPV-21 |
27 | ICP | SCC | -ve | -ve |
NHS | -ve | HPV-7 | ||
28 | ICP | SCC | -ve | HPVx2b |
NHS | -ve | -ve | ||
29 | ICP | SCC | -ve | Unknown HPV type |
30 | ICP | SCC | -ve | RTRX1 |
31 | ICP | SCC | -ve | Unknown HPV type |
32 | ICP | SCC | -ve | HPV-23 rel |
33 | ICP | SCC | -ve | HPV-23 rel |
34 | ICP | SCC | -ve | Unknown HPV type |